Kayne Anderson Rudnick Investment Management
PFE icon

Kayne Anderson Rudnick Investment Management’s Pfizer PFE Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
4,274
+110
+3% +$2.88K ﹤0.01% 578
2026
Q1 		$117K Sell
4,164
-4,183
-50% -$111K ﹤0.01% 540
2025
Q4 		$208K Sell
8,347
-28
-0.3% -$706 ﹤0.01% 498
2025
Q3 		$213K Sell
8,375
-191
-2% -$4.71K ﹤0.01% 498
2025
Q2 		$208K Sell
8,566
-126,353
-94% -$2.95M ﹤0.01% 499
2025
Q1 		$3.42M Sell
134,919
-66,379
-33% -$1.74M 0.01% 297
2024
Q4 		$5.34M Sell
201,298
-531,663
-73% -$14.4M 0.01% 264
2024
Q3 		$21.2M Buy
732,961
+35,454
+5% +$1.03M 0.05% 191
2024
Q2 		$19.5M Sell
697,507
-22,242
-3% -$612K 0.05% 204
2024
Q1 		$20M Sell
719,749
-324,900
-31% -$9.02M 0.05% 199
2023
Q4 		$30.1M Sell
1,044,649
-1,559
-0.1% -$47.1K 0.08% 166
2023
Q3 		$34.7M Sell
1,046,208
-62,296
-6% -$2.2M 0.1% 150
2023
Q2 		$40.7M Buy
1,108,504
+61,948
+6% +$2.41M 0.11% 144
2023
Q1 		$42.7M Buy
1,046,556
+446,618
+74% +$19.3M 0.13% 133
2022
Q4 		$30.7M Buy
599,938
+36,724
+7% +$1.76M 0.1% 154
2022
Q3 		$24.6M Buy
563,214
+143,008
+34% +$6.95M 0.08% 165
2022
Q2 		$22M Sell
420,206
-63,957
-13% -$3.26M 0.07% 173
2022
Q1 		$25.1M Sell
484,163
-9,722
-2% -$504K 0.07% 177
2021
Q4 		$29.2M Sell
493,885
-6,527
-1% -$323K 0.07% 178
2021
Q3 		$21.5M Sell
500,412
-19,301
-4% -$855K 0.05% 185
2021
Q2 		$20.4M Buy
519,713
+12,291
+2% +$478K 0.05% 190
2021
Q1 		$18.4M Buy
507,422
+177,837
+54% +$6.31M 0.05% 189
2020
Q4 		$12.1M Sell
329,585
-10,154
-3% -$372K 0.04% 218
2020
Q3 		$11.8M Buy
339,739
+151,788
+81% +$5.32M 0.04% 207
2020
Q2 		$5.83M Buy
187,951
+117,239
+166% +$3.98M 0.02% 217
2020
Q1 		$2.19M Buy
70,712
+20,408
+41% +$695K 0.01% 250
2019
Q4 		$1.87M Buy
50,304
+17,649
+54% +$629K 0.01% 278
2019
Q3 		$1.11M Buy
32,655
+12,820
+65% +$466K 0.01% 290
2019
Q2 		$815K Buy
19,835
+10,250
+107% +$407K ﹤0.01% 300
2019
Q1 		$386K Buy
+9,585
New +$384K ﹤0.01% 317

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's PFE Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management increased its Pfizer (PFE) stake by 2.6% in Q2 2026, buying an estimated $2.88K and bringing the position to 4,274 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

Kayne Anderson Rudnick Investment Management first reported a position in PFE in Q1 2019 and has held it in 30 quarters since. The position peaked at $42.7M in Q1 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 4,274 shares of Pfizer worth $103K as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management bought 110 Pfizer shares in Q2 2026, an estimated $2.88K.
  • Pfizer made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #578 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Pfizer in Q1 2019 and has held it in 30 quarters since.
  • Kayne Anderson Rudnick Investment Management's Pfizer position peaked at $42.7M in Q1 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.